Dimed S.A. Distribuidora de Medicamentos Stock Sao Paulo
Stocks
PNVL4
BRPNVLACNPR6
Drug Retailers
| Market Cap | 1.66B 327M 286M 265M 243M 459M 31.51B 467M 3.17B 1.24B 15.42B 1.23B 1.2B 53.11B | P/E 2026 * |
9.7x | P/E 2027 * | 8.03x |
|---|---|---|---|---|---|
| Enterprise Value | 1.97B 386M 338M 313M 288M 543M 37.23B 552M 3.74B 1.47B 18.22B 1.45B 1.42B 62.76B | EV / Sales 2026 * |
0.31x | EV / Sales 2027 * | 0.27x |
| Free-Float |
56.77% | Yield 2026 * |
2.78% | Yield 2027 * | 3.14% |
| 1 day | -2.67% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | - | |
| Director of Finance/CFO | 49 | - | |
Alexandre Arnold
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 80 | 01/03/1967 | |
| Chairman | 71 | 02/08/2010 | |
| Director/Board Member | 53 | 17/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.67% | -5.72% | - | - | 325M | |
| +2.85% | +2.63% | -19.75% | -26.17% | 15.14B | |
| +2.68% | -0.58% | -26.60% | -30.44% | 6.93B | |
| +2.53% | +4.48% | -20.28% | -5.91% | 6.13B | |
| +3.36% | +7.06% | -9.08% | -28.23% | 3.73B | |
| +2.36% | +1.93% | -38.19% | -11.11% | 3.25B | |
| -0.39% | -2.17% | -31.14% | -49.78% | 3.13B | |
| +1.35% | +6.63% | +10.77% | -29.70% | 3.12B | |
| -1.88% | -1.59% | +89.80% | - | 2.57B | |
| +0.98% | +3.41% | -18.38% | +1.76% | 2.53B | |
| Average | +1.08% | +1.46% | -6.98% | -22.45% | 5.17B | |
| Weighted average by Cap. | +2.05% | +2.47% | -13.87% | -23.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.28B 1.23B 1.08B 1B 920M 1.73B 119B 1.76B 11.95B 4.69B 58.22B 4.63B 4.53B 201B | 7.23B 1.42B 1.25B 1.15B 1.06B 2B 137B 2.03B 13.77B 5.4B 67.05B 5.34B 5.22B 231B |
| Net income | 171M 33.64M 29.49M 27.26M 25.07M 47.3M 3.24B 48.06M 326M 128M 1.59B 126M 124M 5.47B | 223M 43.89M 38.47M 35.56M 32.7M 61.7M 4.23B 62.69M 425M 167M 2.07B 165M 161M 7.13B |
| Net Debt | 302M 59.38M 52.04M 48.11M 44.24M 83.48M 5.73B 84.82M 575M 225M 2.8B 223M 218M 9.65B | 259M 50.8M 44.53M 41.16M 37.85M 71.42M 4.9B 72.57M 492M 193M 2.4B 191M 187M 8.26B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
